| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors (NCT05131815) | Cedars-Sinai Medical Center | 2022-07-25 |
| Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia (NCT05480501) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-07-11 |
| European Rare Blood Disorders Platform (ENROL) (NCT06250595) | Hospital Universitari Vall d'Hebron Research Institute | 2022-07-01 |
| CD155 Expression in Acute Myeloid Leukemia (NCT06369662) | Assiut University | 2022-07-01 |
| Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) (NCT05403177) | University Health Network, Toronto | 2022-06-23 |
| A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia (NCT05268003) | M.D. Anderson Cancer Center | 2022-06-07 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Early Integration of Palliative and Supportive Care in Cellular Therapy (NCT05190653) | Alberta Health Services, Calgary | 2022-04-08 |
| Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia (NCT05309213) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-04-01 |
| Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families (NCT05425992) | University of Colorado, Denver | 2022-03-17 |
| Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy (NCT05064787) | Pack Health | 2022-03-11 |
| Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia (NCT04961801) | Shin Mineishi | 2022-03-01 |
| Investigating Cognitive Impairment in Young Patients With Cancer Prospectively (NCT05840575) | Rigshospitalet, Denmark | 2022-03-01 |
| Solving Riddles Through Sequencing (NCT05046444) | Munich Leukemia Laboratory | 2022-01-19 |
| Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation (NCT05282459) | Tian Yi Zhang | 2022-01-12 |
| Peppermint Inhalation Versus Swedish Massage on Chemotherapy Induced-Nausea and Vomiting in Children With Leukemia (NCT06095726) | Alexandria University | 2022-01-01 |
| Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia (NCT04541212) | Montreal Heart Institute | 2021-12-02 |
| SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations (NCT05393999) | Imperial College Healthcare NHS Trust | 2021-11-29 |
| Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant (NCT04898790) | University of Nebraska | 2021-11-18 |
| Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies (NCT05203809) | Malaghan Institute of Medical Research | 2021-11-18 |
| Technology-Assisted Yoga and Exercise on Neuropathy and Pain in Children With Leukemia (NCT06512012) | Dokuz Eylul University | 2021-10-30 |
| A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) (NCT05168904) | Cyclacel Pharmaceuticals, Inc. | 2021-10-22 |
| A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia (NCT05743465) | Takeda | 2021-10-06 |
| SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer (NCT04977024) | GeoVax, Inc. | 2021-09-27 |
| Providing Web-based Training to Parents Of Children With Leukemia (NCT06357585) | Saglik Bilimleri Universitesi | 2021-09-24 |
| Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies (NCT05528887) | The Affiliated People's Hospital of Ningbo University | 2021-09-16 |
| A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) (NCT05061147) | Maxinovel Pty., Ltd. | 2021-09-16 |
| Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events (NCT05123001) | Stanford University | 2021-07-15 |
| Removing Transfusion Dependence as a Barrier to Hospice Enrollment (NCT05063591) | Adam Olszewski | 2021-07-09 |
| A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies (NCT04556266) | Memorial Sloan Kettering Cancer Center | 2021-07-01 |
| First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML (NCT04840784) | Shengke Pharmaceuticals Pty Ltd | 2021-06-29 |
| IIT2020-20-SHIRAZIP-WALK: Nature Walks (NCT04896580) | Cedars-Sinai Medical Center | 2021-06-21 |
| Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens (NCT04968834) | Dana-Farber Cancer Institute | 2021-06-11 |
| Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell (NCT05784415) | AIDS Malignancy Consortium | 2021-05-22 |
| The Effect of Mucositis Care Training Given to Caregivers in Pediatric Leukemia Cases on Mucosal Barrier Damage (NCT04813783) | Ege University | 2021-05-01 |
| A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy (NCT04847050) | National Cancer Institute (NCI) | 2021-04-28 |
| Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL (NCT02546739) | Beijing Doing Biomedical Co., Ltd. | 2021-03-01 |
| Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL (NCT03271515) | Beijing Doing Biomedical Co., Ltd. | 2021-03-01 |
| Patient Reported Outcomes and Patient Education in Cellular Therapy Patients (NCT04853277) | Dartmouth-Hitchcock Medical Center | 2021-02-07 |
| Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer (NCT04706676) | Rigshospitalet, Denmark | 2021-01-26 |
| Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies. (NCT04965649) | Centre Hospitalier Universitaire de Nīmes | 2021-01-01 |
| A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT. (NCT04688021) | Yi Luo | 2020-12-03 |
| Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients (NCT04604158) | Gillian Gresham | 2020-12-02 |
| National Longitudinal Cohort of Hematological Diseases (NCT04645199) | Institute of Hematology & Blood Diseases Hospital, China | 2020-12-01 |
| Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study (NCT04372524) | University of British Columbia | 2020-11-15 |
| Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors (NCT04472286) | University of Nebraska | 2020-11-01 |
| Tempus Priority Study: A Pan-tumor Observational Study (NCT05179824) | Tempus AI | 2020-10-19 |
| Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") (NCT04474678) | Medical University of Vienna | 2020-09-07 |
| A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies (NCT04547049) | First Affiliated Hospital of Zhejiang University | 2020-09-01 |
| Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases (NCT04504526) | First Affiliated Hospital of Fujian Medical University | 2020-08-07 |
| Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies (NCT04497701) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2020-08-01 |
| hAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation (NCT03759899) | Peking University People's Hospital | 2020-07-01 |
| Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children (NCT04610125) | Hebei Senlang Biotechnology Inc., Ltd. | 2020-06-23 |
| CAR-37 T Cells in Hematologic Malignancies (NCT04136275) | Marcela V. Maus, M.D.,Ph.D. | 2020-06-19 |
| Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent. (NCT04406285) | Federal University of Health Science of Porto Alegre | 2020-06-01 |
| Natural Killer Cell (CYNK-001) Infusions in Adults with AML (NCT04310592) | Celularity Incorporated | 2020-03-12 |
| Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation (NCT04496011) | Federal University of Health Science of Porto Alegre | 2020-03-02 |
| Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL (NCT04163575) | Kecellitics Biotech Company Ltd | 2020-02-01 |
| Early Diagnosis of Leukemic Children Patients Based on Clinical, Age Estimation and Radiographical Evaluation of Oral Affection (NCT04756258) | Tanta University | 2020-01-30 |
| Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors (NCT03934372) | Incyte Biosciences International Sàrl | 2020-01-29 |
| A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia (NCT03873493) | AbbVie | 2020-01-14 |
| Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies (NCT05011045) | M.D. Anderson Cancer Center | 2020-01-09 |
| Better Leukemia Diagnostics Through AI (BELUGA) (NCT04466059) | Munich Leukemia Laboratory | 2020-01-05 |
| Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas (NCT04101123) | Martin-Luther-Universität Halle-Wittenberg | 2020-01-01 |
| Physical Activity Adapted at Home Supervised by Videoconferencing in Post-cancer for Children / AYA Treated for Leukemia (ONCOPED SAPATIC) (NCT04136665) | University Hospital, Montpellier | 2019-12-14 |
| A Study in Leukemia Patients With Karonudib (NCT04077307) | Thomas Helleday Foundation | 2019-12-03 |
| Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia (NCT04272125) | Chongqing Precision Biotech Co., Ltd | 2019-12-01 |
| Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation (NCT03836690) | University College, London | 2019-10-21 |
| Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia (NCT06155188) | Nanfang Hospital, Southern Medical University | 2019-09-29 |
| Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu (NCT04092803) | University of Colorado, Denver | 2019-09-09 |
| RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation (NCT03948529) | University Hospital, Lille | 2019-09-05 |
| CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia (NCT04265963) | Chongqing Precision Biotech Co., Ltd | 2019-09-01 |
| AZD6738 for Patients With Progressive MDS or CMML (NCT03770429) | Massachusetts General Hospital | 2019-08-05 |
| Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts (NCT03974217) | Dana-Farber Cancer Institute | 2019-08-01 |
| Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia (NCT04037189) | Rabin Medical Center | 2019-07-28 |
| Cardiovascular Effects of CART Cell Therapy (NCT04026737) | Abramson Cancer Center at Penn Medicine | 2019-07-22 |
| Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia (NCT03759184) | National Cancer Institute (NCI) | 2019-07-11 |
| A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients (NCT03677596) | Pfizer | 2019-07-01 |
| ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma (NCT04014894) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2019-06-12 |
| CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma (NCT04271410) | Chongqing Precision Biotech Co., Ltd | 2019-06-01 |
| HeartPhone Cancer Survivors Trial 2019 (NCT03953326) | Penn State University | 2019-04-23 |
| Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy (NCT03910842) | Timmune Biotech Inc. | 2019-03-21 |
| PROactive Evaluation of Function to Avoid CardioToxicity (NCT03862131) | Washington University School of Medicine | 2019-03-13 |
| Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL (NCT03708003) | Swiss Cancer Institute | 2019-03-11 |
| Clozapine and Haematologic Malignancies: Observational and Retrospective Study Using the WHO Pharmacovigilance Database (NCT04074213) | University Hospital, Caen | 2019-03-01 |
| Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers (NCT03538587) | National Cancer Institute (NCI) | 2019-01-29 |
| Immunophenotyping of Blast Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From AML and MDS Patients (AML) (NCT03801005) | Assistance Publique Hopitaux De Marseille | 2019-01-09 |
| Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation (NCT04336501) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2019-01-01 |
| A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations (NCT03793140) | Memorial Sloan Kettering Cancer Center | 2018-12-31 |
| Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia (NCT03826992) | Children's Hospital Medical Center, Cincinnati | 2018-12-27 |
| CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma (NCT03684889) | Seattle Children's Hospital | 2018-11-28 |
| Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer (NCT03654716) | Dana-Farber Cancer Institute | 2018-11-01 |
| Resiliency in Older Adults Undergoing Bone Marrow Transplant (NCT04188678) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-09-28 |
| A Study on the Uterus, Ovarian and Reproductive Functions According to Conditioning Regimen and Pubertal Status at the Time of Stem Cell Transplantation in a Leukemia Pediatric Population (NCT03583294) | Assistance Publique Hopitaux De Marseille | 2018-07-01 |
| Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant (NCT03057054) | Children's Oncology Group | 2018-04-30 |
| Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) (NCT03496402) | Institut Curie | 2018-04-20 |
| A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies (NCT03404726) | Bayer | 2018-03-29 |
| Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation (NCT03342196) | Case Comprehensive Cancer Center | 2018-03-21 |
| Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies (NCT03624686) | National Taiwan University Hospital | 2018-03-09 |
| Respiratory Training in Patients With Leukemia (NCT03876834) | Cairo University | 2018-03-01 |